Psychological resilience predicts medication adherence in multiple sclerosis

A study of 165 people with relapsing-remitting multiple sclerosis found that psychological resilience independently predicts better medication adherence to disease-modifying therapies, even after accounting for depression, anxiety, stress, quality of life, and disability level. Those with good adherence showed significantly higher resilience scores and lower psychological distress compared to poorly adherent patients.